Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jenene Thomas Communications LLC ("JTC") is an active U.S.-based advisory firm specializing in investor relations and corporate communications for biotechnology, pharmaceutical, and healthcare companies. Founded by industry veteran Jenene Thomas in 2013, JTC leverages deep sector expertise to help life sciences organizations build visibility among investors and stakeholders through integrated communication strategies. The company does not develop drugs or own therapeutic pipelines but plays a key role as an external partner to many health-focused organizations seeking capital markets engagement or enhanced public profiles.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jenene Thomas Communications.